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ABSTRACT
An increasing observation is that some patients with 
COVID-19 have normal lung compliance but significant 
hypoxaemia different from typical acute respiratory 
distress syndromAcute Respiratory Distress Syndrome 
(ARDS). We hypothesised that changes in pulmonary 
blood distribution may be partially responsible and used 
functional respiratory imaging on CT scans to calculate 
pulmonary blood volume. We found that patients with 
COVID-19 had significantly reduced blood volume 
in the smaller calibre blood vessels (here defined as 
<5 mm2 cross- sectional area) compared with matched 
ARDS patients and healthy controls. This suggests that 
using high levels of PEEP may not alone be enough 
to oxygenate these patients and that additional 
management strategies may be needed.
INTRODUCTION
The COVID-19 pandemic has resulted in a propor-
tion of patients progressing to respiratory failure and 
needing mechanical ventilation.1 This has caused 
significant challenges worldwide with both hospital 
ventilatory capacity and ventilation strategies for 
individual patients. Conventional wisdom for the 
management of acute respiratory distress syndrome 
(ARDS) involves use of mechanical ventilation 
with high levels of positive end- expiratory pres-
sure (PEEP) to recruit lungs by exerting mechanical 
pressure on alveoli and compressing leaky capil-
laries located within the interstitial space.2 This 
use of high PEEP reduces the right- to- left shunt 
and allows the inspired fraction of oxygenation to 
become effective at oxygenating the blood.
However, there is an increasing observation that 
some patients with COVID-19 present with respira-
tory failure with a significant hypoxaemia but retain 
preserved lung function with normal compliance, 
which is different to typical ARDS.3 The mech-
anisms of this are not understood, but a number 
of groups have hypothesised that an abnormal 
vascular response may be responsible. We investi-
gated this further by applying a novel method of 
image analysis to investigate the blood volume and 
distribution within the lungs of these patients.
Functional respiratory imaging (FRI) creates 
3D reconstructions of the airways and pulmonary 
vasculature from CT scans to calculate both airway 
size and blood volume in the pulmonary circula-
tion.4 5 Smoking- related chronic obstructive pulmo-
nary disease has been characterised by distal pruning 
of small blood vessels, the magnitude of which 
change predicts the clinical severity of disease.4 
Studies have shown that computer modelling of 
blood volume within the lungs is a strong correlate 
to histological markers of vascular change.6
METHODS
We used FRI coupled with an automated blood 
vessel segmentation algorithm to perform an eigen-
value analysis of the Hessian matrix to enhance and 
identify tubular structures, returning the proba-
bility of each voxel belonging to tubular structure 
based on shape analysis. To account for effects of 
CT slice thickness on results, sensitivity analysis 
was performed. Volumes of blood were computed 
from the cross- sectional area of each blood vessel 
with <5 mm2 defined as small vessels (BV5) and 
>10 mm2 as large vessels (BV10), as previously 
defined by others.6 To account for differences in 
lung volume between individuals, we calculated 
blood volume within a vessel as a percentage of total 
blood volume through the lungs of each patient.
We performed FRI on CT scans from 10 intu-
bated patients with COVID-19 (9 taken at initiation 
of venous–venous extracorporeal membrane circu-
lation (VV- ECMO)) from a tertiary UK lung centre 
and compared them with data from 7 intubated 
patients without COVID-19 ARDS and a retrospec-
tive set of 107 healthy volunteers. The study was 
approved by the Royal Papworth R and D committee 
(ref. S02467). Patients with COVID-19 had scans 
taken at a PEEP of 10 cmH2O; patients with ARDS 
had scans taken at PEEP 0 and 20 (figure 1). All 
group comparisons were made using Kruskal- Wallis 
test; between- group comparisons were calculated 
using Mann- Whitney test. Statistical analysis was 
performed with R V.3.6.1 (R Foundation for Statis-
tical Computing, Vienna, Austria).
RESULTS
The groups were matched in terms of age, sex, 
height and premorbidity. The patients with 
COVID-19 had a higher body mass index (median 
31, range 28.4–35.1) than patients with ARDS 
(median 26, range 24.8–28.4) (p=0.015). The 
FRI results showed that the distribution of blood 
volume was different between groups (figures 2 and 
3). Patients with COVID-19 had significantly less 
total blood within small- calibre pulmonary blood 
vessels (BV5, defined as those with a cross- sectional 
area of <5 mm2) compared with ARDS and healthy 
controls (p=0.005, COVID-19 vs ARDS PEEP0; 
p=0.005, COVID-19 vs ARDS PEEP20; p<0.001, 
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COVID-19 vs healthy). Conversely, they had a significantly 
higher proportion of blood volume within large- calibre vessels 
(BV10, cross- sectional area of >10 mm2) (p=0.007 COVID-19 
vs ARDS PEEP0, p=0.009 COVID-19 vs ARDS PEEP20, 
p<0.001 COVID-19 vs healthy). Blood pressure, arterial pH 
and right ventricular function in the COVID-19 group were 
within normal parameters. Total pulmonary blood volume was 
similar between all groups.
DISCUSSION
Our findings suggest that the impaired gas exchange seen in 
COVID-19 may be partially a result of redistribution of blood 
away from the small- calibre pulmonary vessels. The mechanisms 
of this could be increased vascular resistance due to either vaso-
constriction of distal pulmonary arteries or presence of micro-
thrombi or both. Patients with COVID-19 have a high incidence 
of thrombotic complications with 31% from one large Dutch 
intensive care unit study having complications, including acute 
pulmonary embolism, deep- vein thrombosis and ischaemic 
stroke.7 Postmortem studies reveal frequent pulmonary 
microthrombi despite anticoagulation.8 More recently, a spec-
trum of vascular inflammation similar to Kawasaki disease has 
been reported as a late sequelae in some children.9
The main limitations of this study are the small numbers of 
patients investigated and that patients with COVID-19 had scans 
taken at initiation of VV- ECMO and may therefore have had a 
worse spectrum of lung disease compared with the ARDS group. 
However, given that cardiac indices in the COVID-19 group (as 
measured at the time of CT scan) was within normal parameters 
and total pulmonary blood volume (as measured by FRI) was not 
different between groups, it suggests an intrinsic difference in 
blood distribution which is not related to either cardiac function 
or total amount of blood within the pulmonary vessels. Interest-
ingly, we did not find a difference in pulmonary blood distribu-
tion between patients with ARDS and healthy volunteers. There 
is no clear evidence for small vessel abnormalities in standard 
ARDS where a lung infection causing alveolar damage is the 
primary driver of hypoxaemia, but it may also be that our ARDS 
sample size was not large enough to identify these.
Our findings are consistent with a recent postmortem study 
Figure 1 (A) Vascular blood flow through a patient with COVID-19. (B) Vascular blood flow through a patient with ARDS. Colours indicate vessel 
cross- sectional area. ARDS, acute respiratory distress syndrome.
Figure 2 Total amount of blood flow through all blood vessels as measured by cross- sectional area (0–20 mm2). (B) Total amount of blood flow 
through all blood vessels as measured by cross- sectional area (0–100 mm2). Patients with COVID-19 had scans taken at PEEP 10 cmH2O, ARDS at 
PEEP 20 cmH2O. ARDS, acute respiratory distress syndrome.
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which found that alveolar microthrombi were present at nine 
times the burden in COVID-19 compared with a matched ARDS 
group. The pattern of damage in both lungs was consistent with 
diffuse alveolar damage and perivascular T- cell infiltration. 
However, the COVID-19 group showed small blood vessels 
with structurally deformed capillaries which were elongated 
and displayed sudden changes in calibre with the presence of 
intussusceptive pillars.10 This suggests histologically a disorder 
in the small blood vessels, a finding confirmed by our radiology 
analysis. Our data also confirm that of others to suggest high 
PEEP to recruit lungs may not be beneficial in these patients1 but 
that measures to increase blood flow to the small blood vessels, 
including sufficient anticoagulation if concerns of pulmonary 
microthrombi or the use of pulmonary vasodilators, should 
be considered as part of the overall management strategy for 
these patients. Further studies with larger sample sizes should be 
performed to confirm our findings.
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ARDS, acute respiratory distress syndromAcute Respiratory Distress Syndrome; BV5, blood vessel volume for vessels less than 5 mm2; BV10, blood 
vessel volume for vessels more than 10 mm2; TBV, total blood vessel volume. Mann- Whitney test was used for all between- group comparisons.
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